NDC | 15579-837-23 |
Set ID | 1fe1f806-cbf3-4308-8d70-201756e96cd1 |
Category | HUMAN OTC DRUG LABEL |
Packager | Bell Pharmaceuticals, Inc. |
Generic Name | |
Product Class | Antiemetic |
Product Number | |
Application Number | PART336 |
- Drug Facts
- Active ingredient (in each tablet)
- Uses
- Warnings
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucome
- difficulty in urination due to enlargement prostate glad
When using this product
• drowsiness may occur • alcohol, sedatives, and tranquilizers may increase drowsiness • avoid alcoholic drinks • be careful when driving or operating machinery
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
- Directions
- take first dose one hour before starting activity
adults and children 12 years and over take 1 to 2 tablets once daily, or as directed by a doctor children under 12 years do not ues unless directed by doctor - Other information
- store at room temperature between 59°-86°F (15°-30°C)
- protect from excessive moisture
- don not use if tamper-evident seal is broken or missing
- Inactive ingredients
calcium stearate, FD&C red#40 aluminum lake, lactose, microcrystalline cellulose, silicon dioxide, sodium starch glycolate
Close - Questions or comments?
- Package Labeling:
- INGREDIENTS AND APPEARANCE
JET-AVERT MOTION SICKNESS AID
meclizine hydrochloride tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:15579-837 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE 25 mg Inactive Ingredients Ingredient Name Strength CALCIUM STEARATE (UNII: 776XM7047L) FD&C RED NO. 40 (UNII: WZB9127XOA) LACTOSE (UNII: J2B2A4N98G) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color red Score no score Shape ROUND Size 4mm Flavor Imprint Code 25 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:15579-837-23 3 in 1 BOX 10/07/2017 1 8 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part336 10/07/2017 Labeler - Bell Pharmaceuticals, Inc. (140653770)